Related Experiment Videos
Regression of cardiovascular structural changes--a preventive strategy
1Department of Medicine, University of Gothenburg, Ostra Hospital, Sweden.
Insights
Lowering blood pressure with antihypertensive therapy may reverse cardiac and vascular structural changes. Early intervention is key for optimal regression, potentially improving cardiovascular outcomes.
Area of Science:
- Cardiology
- Hypertension Research
- Vascular Biology
Background:
- Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular disease.
- Structural vascular changes contribute to the development and progression of hypertension.
- Reversing these structural changes is a logical preventive strategy for hypertension.
Purpose of the Study:
- To review the effects of antihypertensive therapy on structural cardiovascular changes.
- To explore the potential for regression of LVH and vascular remodeling.
- To assess the impact of regression on hypertension progression and cardiovascular health.
Main Methods:
- Review of studies on animal models of hypertension.
- Analysis of clinical trials in humans undergoing antihypertensive therapy.
- Examination of data on cardiac and vascular structural changes.
Main Results:
- Prolonged blood pressure normalization, ideally initiated early, is optimal for regression.
- Regression of cardiac hypertrophy may improve cardiac function and reduce arrhythmias.
- Regression of vascular changes may positively influence hypertension progression.
Conclusions:
- Antihypertensive therapy can induce regression of structural cardiovascular changes.
- Early and sustained blood pressure control is crucial for achieving regression.
- Further research is needed to determine the impact of regression on mortality and morbidity associated with LVH.
Abstract:
Left ventricular hypertrophy is an independent "risk factor" for all kinds of cardiovascular disease. Structural vascular changes are of importance for the maintenance and progression of high blood pressure. To try to achieve regression of these structural changes seems a logical option as part of a preventive strategy in hypertension. The effect of antihypertensive therapy on structural cardiovascular changes in animal models and man is reviewed. A prolonged normalization of blood pressure without reflexogenic activation of trophic factors, if possible started early in the development of hypertension seems to be the optimal therapy to attain regression. There are some data indicating that regression of cardiac hypertrophy can improve cardiac function and reduce arrhythmias and furthermore that regression of structural vascular changes can positively affect the progression of hypertension. Although these preliminary result look promising there are still no data on how regression induced by antihypertensive therapy affects the mortality and morbidity associated with left ventricular hypertrophy.